Paloma Partners’s ResMed RMD Stock Holding History

Paloma Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,000	Closed	-$191K	–	1606
2024 Q2	$191K	Buy	+1,000	New	+$203K	0.01%	1005
2021 Q1	–	Sell	-4,500	Closed	-$956K	–	2315
2020 Q4	$956K	Sell	4,500 -200	-4%	-$39.9K	0.03%	590
2020 Q3	$806K	Buy	+4,700	New	+$868K	0.02%	865

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Paloma Partners's RMD Position: Q4 2024 in Review

Paloma Partners sold out of ResMed (RMD) in Q4 2024, closing a stake of 1,665 shares — an estimated $406K sold.

Paloma Partners first reported a position in RMD in Q2 2013 and held it in 25 quarters. The position peaked at $5.67M in Q1 2021. 871 funds tracked by Wall St. Rank hold RMD as of Q4 2024.

Paloma Partners reported no remaining ResMed position as of Q4 2024 after selling out during the quarter.
Paloma Partners sold 1,665 ResMed shares in Q4 2024, an estimated $406K.
Paloma Partners first reported a position in ResMed in Q2 2013 and held it in 25 quarters.
Paloma Partners's ResMed position peaked at $5.67M in Q1 2021.
871 funds tracked by Wall St. Rank held ResMed as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.